Patents Assigned to Dimera, LLC
  • Method for reducing coronary artery reactivity
    Patent number: 6511969
    Abstract: A method for reducing coronary artery reactivity. A predetermined amount of natural progesterone is provided by a convenient and pleasant delivery system to the blood stream, sufficient to reduce the likelihood of coronary vasospasm and myocardial ischemia. The progesterone may be provided either by topical application to the epidermis of a cream in which the progesterone is dissolved or by patch technology, so as to provide continuous delivery and thereby maintain the level of progesterone in the blood stream at least about 1 nanogram per milliliter.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: January 28, 2003
    Assignee: Dimera, LLC
    Inventor: R. Kent Hermsmeyer
  • Method for reducing coronary artery reactivity
    Patent number: 6056972
    Abstract: A method for reducing coronary artery reactivity. A predetermined amount of natural progesterone is provided by a convenient and pleasant delivery system to the blood stream, sufficient to reduce the likelihood of coronary vasospasm and myocardial ischemia. The progesterone may be provided either by topical application to the epidermis of a cream in which the progesterone is dissolved or by patch technology, so as to provide continuous delivery and thereby maintain the level of progesterone in the blood stream at least about 1 nanogram per milliliter.
    Type: Grant
    Filed: February 6, 1998
    Date of Patent: May 2, 2000
    Assignee: Dimera, LLC
    Inventor: R. Kent Hermsmeyer